Thank you to our speakers, sponsors, and delegates who joined us in Boston last year for this summit! If you are interested in the 2024 event, please get in touch at info@hansonwade.com

Next in the CNS series Banner... Neuroimmunology Drug Development Summit 2024

Innovating, Validating & Enabling Digital Biomarker & Endpoint Acceptance in CNS

Driving the Digital Revolution of Objective, Sensitive, & Non-Invasive Measures in CNS

With 3 days of jam-packed content and 32+ digital health expert speakers, the 2nd Digital Biomarkers & Clinical Measures in Neuro Summit was biopharma’s can’t-miss meeting for the innovation, validation, and acceptance of digital biomarkers endpoints in CNS pipelines.

80+ of your digital health and CNS clinical development peers addressed the standardization and regulatory acceptance of digital tools and data analysis as endpoints in complex neurological indications, discover novel innovations for objective, sensitive, and non-invasive neurological measures, and ensure internal confidence and scalability with emerging digital technologies.

What You Missed in 2023:

  • Brand-New Presenting Pharma Companies: Network and hear from new experts from Regeneron, Lundbeck, AbbVie, Pfizer, and Servier, showcasing their latest work developing novel digital measures and devices to sensitively and objectively tackle neurological indications.
  • 12 Hours of Pre-Conference Workshop Content: With 2 workshop streams dedicated to data scientists and neurology translational scientists, join these 3-hour interactive sessions to deep-dive into the latest innovations in big data analysis, data standardization, regulatory requirements, and industry confidence and scalability.
  • Patient Advocate Discussion: Hear directly from patients and advocates involved in digital measure clinical research to understand the patient perspective on meaningful digital measure development and remote trial participation.

2023 Highlights

Brand-New Presenting Pharma Companies: Network and hear from new experts from Regeneron, Lundbeck, AbbVie, Pfizer, and Servier showcasing their latest work developing novel digital measures and devices to sensitively and objectively tackle neurological indications.

12 Hours of Pre-Conference Workshop Content: With 2 workshop streams dedicated to data scientists and neurology translational scientists, join these 3-hour interactive sessions to deep-dive into the latest innovations in big data analysis, data standardization, regulatory requirements, and industry confidence and scalability

Patient Advocate Discussion: Hear directly from patients and advocates involved in digital measure clinical research to understand the patient perspective on meaningful digital measure development and remote trial participation

2023's World-Class Speaker Faculty:

Previously Attending Companies Include:

Hear from the Previous Attendees:

"I never expected to make such genuine connections around our shared, deep interest in digital biomarkers, or to learn that I am not alone in the technical, operational, or regulatory challenges I face”

Raul Torres, Principal Data Scientist, Takeda

2023 Partners:

Altoida_Logo
nl-light-logo (002)
Red Nucleus logo
vivosense-logo-
clightlogo_transparent_stacked
Cognivuelogo_color_RGB_Reg_R (22)

Other Events in the World CNS Series: